Comparison of -arrestin induced receptor internalization for GLP-1 agonists like exendin-4, semaglutide, retatrutide, and tirzepatide using the PathHunter GLP-1R Activated Internalization Assay
The real question is this: are body aches actually caused by the medication, or are there other factors at play
[PMID: 40850442] PubMed record related to this compound for laboratory literature review
As included in the board's legislative report, the board is hoping to remove some of the overly prescriptive requirements in pharmacy law that have become barriers to care
So when you remove the GLP-1 medication, that patient is set back on a course of weight increase. In other words, without the medication to block and promote pathways that can affect a bodys biochemistry, a person is more likely to return to consuming more calories and regaining weight